Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Equity Ratio (2016 - 2021)

Historic Equity Ratio for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to 0.86.

  • ENDRA Life Sciences' Equity Ratio rose 3810.16% to 0.86 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.86, marking a year-over-year increase of 3810.16%. This contributed to the annual value of 0.82 for FY2020, which is 2329.86% up from last year.
  • Latest data reveals that ENDRA Life Sciences reported Equity Ratio of 0.86 as of Q3 2021, which was up 3810.16% from 0.87 recorded in Q2 2021.
  • ENDRA Life Sciences' 5-year Equity Ratio high stood at 0.98 for Q2 2017, and its period low was 2.53 during Q1 2017.
  • Over the past 5 years, ENDRA Life Sciences' median Equity Ratio value was 0.77 (recorded in 2018), while the average stood at 0.51.
  • As far as peak fluctuations go, ENDRA Life Sciences' Equity Ratio tumbled by 13696.31% in 2018, and later surged by 20953.48% in 2019.
  • Quarter analysis of 5 years shows ENDRA Life Sciences' Equity Ratio stood at 0.86 in 2017, then grew by 0.42% to 0.87 in 2018, then dropped by 23.31% to 0.66 in 2019, then grew by 23.3% to 0.82 in 2020, then rose by 5.03% to 0.86 in 2021.
  • Its Equity Ratio was 0.86 in Q3 2021, compared to 0.87 in Q2 2021 and 0.94 in Q1 2021.